News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
Friday, November 15, 2024PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of LaNeo MDMA and novel derivatives of MDMA MDXX class molecules has signed a Letter of Intent with a research institution to provide its LaNe...
Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies
Thursday, November 14, 2024Continuity Biosciences LLC a new bioscience company dedicated to developing and commercializing cuttingedge technologies for cell reprogramming immune modulation and drug delivery is excited to announce its official launch The company seeks to bridge...
WuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line
Thursday, November 14, 2024WuXi Biologicsa leading global Contract Research Development and Manufacturing Organization CRDMO announced that it will enhance its drug product DP capabilities at the companys facility in Leverkusen Germany with a new sterile filling line for prefi...
QIAGEN collaborates with McGill University to advance microbiome research
Wednesday, November 13, 2024QIAGEN announced a collaboration with the McGill University Centre for Microbiome Research to support microbiome research activities and outcomes The threeyear partnership will further drive microbiome sciences the study of a community of microorgan...
Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist
Wednesday, November 13, 2024Nxera Pharma Co Ltd formerly known as Sosei Group or Sosei Heptares notes that Centessa Pharmaceuticals has initiated a Phase trial of ORX an investigational orally administered highly potent and selective orexin receptor
ResQ Pharma Receives PDUFA Date for LipidRescue™ as a Potential First-Ever, FDA-approved Treatment for LAST
Tuesday, November 12, 2024ResQ Pharma Inc a Chicagobased pharmaceutical company developing and commercializing innovative drug therapies today announced that it has received a PDUFA Prescription Drug User Fee Act date of June for its LipidRescue Kit If approved
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
Tuesday, November 12, 2024AdipoPharma a biotech company based in France with offices in the US and Belgium announced today it has successfully secured the funding required to commence Phase clinical trials for its promising new Type diabetes treatment The company is set to...
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
Monday, November 11, 2024CanFite BioPharma Ltd a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases today announces the dosing of the first patient in the Phase IIa clinical trial in patients wit...
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Friday, November 08, 2024Cytek Biosciences Inc has introduced an Enhanced Small Particle ESP Detection Option for its Cytek Aurora CS system This is the first commercially available small particle detector on a cell sorter and offers a significant advancement for rapidly evo...
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Friday, November 08, 2024Aptar Pharma a global leader in drug delivery and active material science solutions and services today announced that it has entered into an exclusive collaboration agreement with Cambridge Healthcare Innovations CHI to lead the commercialization and...
